Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

The AVET system effectively delivers genes to human keratinocytes and may help treat skin diseases.

Antiandrogens help improve developmental delays caused by valproic acid in rats.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

The steroids allopregnanolone and allotetrahydrodeoxycorticosteron worsened absence seizures in rats.

Keyora Lycopene 23 in 1 Man's Multi-Vitamin improves male reproductive health and metabolism.

Sphingosine 1-phosphate and its receptor S1PR3 are key in controlling mechanical pain.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

L-threonate may help prevent balding by blocking a key protein.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Targeting catecholaminergic signaling may help treat keloid scars.

Removing vitamin D and calcium receptors in mice skin cells slows down skin wound healing.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Minoxidil stops cells from making prostacyclin, which may help with hair growth. More research is needed.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

Analog 23 is a promising compound for prostate cancer treatment.

Polyamidoamine dendrimers can change the strength and direction of electroosmotic flow through the skin, affecting drug delivery.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Improved CRBN ligands make protein degraders more effective and drug-like.

Some blood thinners can cause hair loss, but switching medications can stop it.